Kent G, al-Abadie M
Department of Psychiatry, University of Sheffield Medical School, UK.
Clin Exp Dermatol. 1996 Sep;21(5):330-3.
Finlay and Khan have recently suggested that the Dermatology Life Quality Index (DLQI) can be used to measure the effects of dermatological conditions on the quality of patients' lives. The aims of this study were to assess its applicability in a nonclinic sample of vitiligo sufferers and to measure its relationship with questionnaires designed to measure a variety of psychological and demographic factors. The DLQI was completed by 614 members of the Vitiligo Society in a postal survey. The results supported the validity of the DLQI for this sample. DLQI scores were related to perceived stigma (a version of Ginsburg and Link's psoriasis stigma questionnaire), recent experiences, self-esteem (Rosenberg's scale), personal distress (both a symptom checklist and the 12-item General Health Questionnaire) and race, suggesting that levels of disability might be reduced by interventions that target these variables.
芬利和汗最近提出,皮肤病生活质量指数(DLQI)可用于衡量皮肤病对患者生活质量的影响。本研究的目的是评估其在白癜风患者非临床样本中的适用性,并测量其与旨在测量各种心理和人口统计学因素的问卷之间的关系。在一项邮寄调查中,白癜风协会的614名成员完成了DLQI。结果支持了DLQI对该样本的有效性。DLQI得分与感知耻辱感(金斯堡和林克银屑病耻辱感问卷的一个版本)、近期经历、自尊(罗森伯格量表)、个人困扰(症状清单和12项一般健康问卷)以及种族相关,这表明针对这些变量的干预措施可能会降低残疾水平。